Autotransfusion Devices Market Growth, Size & Industry Forecast - 2027
The growth of the market is driven by factors such as the
involvement of rare blood groups, rising number of transplant procedures, and
rising prevalence of chronic diseases in the North America region. Whereas,
risks associated with autotransfusion is likely to have a negative impact on
the growth of the market in the coming years.
The autotransfusion process involves the reinfusion of the
patient's blood. Blood is collected from the peritoneal cavity or thorax
region. The process can be carried out before surgery or during and after the
surgery using the autotransfusion system. Medical procedures, like joint
replacement, spinal surgeries, and cardiac, among others, require
autotransfusion. It helps to reduce the risk of infection, and also it
eliminates the problems and complications associated with the banking and
administration of homologous donor blood. It helps to prevent the transmission
of transfusion-related blood-borne diseases in patients.
Key Players
Influencing the Market:
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet.
The autotransfusion systems are widely used in various
surgical procedures such as cardiac surgery, trauma procedures, orthopedic
procedures, and other invasive procedures. These procedures are followed by
excessive blood loss, and it is difficult to obtain blood of rare group in
emergency cases. Autotransfusion system facilitates to reinfuse the patient’s
blood back into the body after the due filtration process.
For instance, in the US blood group AB positive is among the
rarely found blood group about 196.94 million (0.6%) of the population in 2019
in such cases of rare blood group is difficult to arrange in case if urgent
equipment during surgical procedures. Thus, the autotransfusion system is one
of the procedures useful for patients with rare blood groups, where the
patient’s blood is reinfused in the body. This can be done efficiently with use
of appropriate type of autotransfusion devices. Owing to these facts, the cases
of involvement of rare blood group are likely to boost the market in the coming
years.
The need for reinfusion of blood and robust advancements in
healthcare facilities and infrastructure in North America is expected to drive
the growing in the country create a lucrative opportunity and the presence of
an established market for autotransfusion devices.
Purchase for Report @
https://bit.ly/3avARp0
Key Benefits:
- This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.
- In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
- Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.
Source :
Business Market Insights
Comments
Post a Comment